drugset / Trial / NCT01557647
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effect of inhaled treprostinil compared to placebo on exercise capacity and time to clinical worsening.
Timeline
- Start
- 2012-06
- Primary completion
- 2015-12
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 0.6 mg/ml | Inhaled |